The Trump Administration has imposed tariffs on nearly $5 billion of US imports of medical products from China, which accounts for roughly 26 percent of all medical products imported from all countries. Facing potential supply shortages, the Administration published an announcement in the Federal Register on March 16, 2020, that…
Author
Thomas Peele
BrowsingTom Peele mainly handles trade regulatory matters such as antidumping and countervailing duty cases and litigation work involving foreign states and their agencies and instrumentalities. In addition to the Firm's Washington DC office, Mr. Peele also has experience working in Baker McKenzie's Beijing and Hong Kong offices. He has written a number of reports and articles for various publications on the law of foreign sovereign immunity and trade remedies. He was a Danforth Graduate Fellow and a Woodrow Wilson Fellow and the recipient of the Joseph R. Levenson Award in Chinese Studies.